NYSE:BSX   Boston Scientific Corporation
BSX

From a technical standpoint #BSX is reporting a divergence between RSI and Price, in addition the MACD is sloping up leading us to think that a move to the upside is imminent.
The MACD, still below 0, correctly describe the negative momentum: we expect for the near future to retest the upper end of the downward channel at $ 36.50.

Buy price: $ 33.69
1st target: $ 35.00
2nd target: $ 36.00
Stop loss: $ 32.80
Trade closed: target reached

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.